Search results
Results from the WOW.Com Content Network
Between 1 and 30 per 10,000 people are affected by Brugada syndrome. [1] [2] Although those affected are born with the condition, symptoms typically only begin in adulthood. While the rare cases seen in childhood are equally likely to be male or female, in adulthood symptoms occur more frequently in males than females, potentially due to the ...
Long QT syndrome, the most common form of cardiac channelopathy, is characterized by prolonged ventricular repolarization, predisposing to a high risk of ventricular tachyarrhythmias (e.g., torsade de pointes), syncope, and sudden cardiac death.
Long QT syndrome is estimated to affect 1 in 7,000 people. [6] Females are affected more often than males. [6] Most people with the condition develop symptoms before they are 40 years old. [6] It is a relatively common cause of sudden death along with Brugada syndrome and arrhythmogenic right ventricular dysplasia. [3]
Brugada syndrome is a genetic disease that can result in mutations in the sodium ion channel (gene SCN5A) of the myocytes in the heart. [10] Brugada syndrome can result in ventricular fibrillation and potentially death. It is a major cause of sudden unexpected cardiac death in young, otherwise healthy people. [11]
Big 12 Commissioner Brett Yormark presenting Arizona State with the title trophy and doing a little CFP politicking: "The last six weeks, there has not been a better team in college football than ASU.
Ms Coffey, 53, from Manchester, New Hampshire, was diagnosed with breast cancer in 2013 and later fell ill with complex regional pain syndrome, a potentially debilitating neurological condition.
4. You Hate Being Nickeled and Dimed. Sure, a lot is included in the cost of a cruise, including accommodations, most food, and entertainment. But there's a long list of things that will rack up ...
Long QT syndrome, Brugada syndrome, Andersen-Tawil syndrome, Early repolarization syndrome: Treatment: Avoidance of strenuous exercise, medication, implantable cardioverter defibrillator [2] Medication: Beta-adrenoceptor blockers, Verapamil, Flecainide [2] Prognosis: 13–20% life threatening arrhythmias over 7–8 years [3] Frequency: 1:10,000 [4]